Journal Watch
-
Benefits of PD Remote Monitoring
A retrospective study compared two groups of APD patients, one that received remote monitoring (n=38) and one that received routine care (n=35). PD dropout and fluid status were similar between the two groups. But, the remote monitoring group had fewer ER and hospital visits related to kidney disease, especially among those with more comorbidities. Patients also preferred remote monitoring, and were more satisified with their care.
Read the abstract » | (added 2020-09-11)
Tags: Clinical Outcomes, Quality Of Life, Remote Monitoring, Telemedicine
-
PD vs. Standard HD for Cognitive Function
A metaanalysis of papers including 195,774 patients looked at whether PD or standard in-center HD better supported cognitive function. The authors found significantly less risk of cognitive impairment among those who did PD.
Read the abstract » | (added 2020-09-11)
Tags: Cognitive, Renal Failure
-
Advantages of PD in Primary Glomerulonephritis (PGN)
A prospective observational study followed all incident PD patients (n=2,243) who had PGN in the Levante registry from 1995 to 2014. Compared to other diagnoses, those with PGN had a significantly lower rate of peritonitis and better mean survival. The authors conclude that “PD has several advantages as a first dialytic treatment, and our results suggest that it is an excellent technique to manage patients with PGN while they await a kidney transplant.”
Read the abstract » | (added 2020-09-11)
Tags: Patient Survival, Peritoneal Dialysis, Primary Glomerulonephritis
-
International Use of PD
Worldwide PD use is approximately 11%, which varies across the globe, finds a new survey of stakeholders in 182 countries (with 313 respondents from 160 countries). Median PD use was 38.1 per million. Thirty countries, mainly low-income, did not offer PD, while in 69% of countries, PD was the first modality for <10% of incident patients. The range of PD costs passed on to patients was 1-25%, with higher co-pays in South Asia and low-income countries. Patient-reported PD outcomes were rarely measured.
Read the abstract » | (added 2020-09-11)
-
SARS-CoV-2 in PD Effluent
Analysis of bodily fluids from 3 SARS-CoV-2-infected PD patients found that, while viral load was quite high in nasopharyngeal swabs, none of the PD effluent tested positive, even after dialysate concentration. This suggests that the risk of virus transmission from used PD fluid may be low.
Read the abstract » | (added 2020-09-11)
Tags: COVID 19, SARS CoV 2, Peritoneal Dialysis
-
International Use of HD—Including Home HD
A new survey of stakeholders in 182 countries (with respondents from 160 countries) found a use rate for HD of 298.4 per million. Among incident dialysis patients, the HD rate was 98.0. Standard in-center HD was available among 27% of low-income countries (and these patients paid more of the costs); home HD was available in 36% of high-income countries. Monitoring of patient-reported outcomes was done in 61% of countries, while 60% monitored bone minerals and patient survival, and 51% monitored technique survival. Just 5% of countries initiated patients on HD with arteriovenous access.
Read the abstract » | (added 2020-09-11)
Tags: Hemodialysis, Homedialysis, HD
-
Serum Uric Acid and Residual Kidney Function in PD
In a study of 201 CAPD patients followed for up to 8 years (median 23.43+ 16.6 months), high or low serum uric acid and peritonitis were independent risk factors for loss of all residual kidney function. Higher weekly Kt/V urea helped protect residual function.
Read the abstract » | (added 2020-08-11)
Tags: Residual Renal Function, Uric Acid
-
Carnitine Deficiency and ESA Resistance in PD
Among 60 PD patients, 56 had carnitine deficiency, which was found to independently predict ESA resistance.
Read the abstract » | (added 2020-08-11)
Tags: Carnitine Deficiency, Peritoneal Dialysis, Erythropoietin Resistance Index
-
How Much Dialysate Should be Used for Nocturnal HD With NxStage?
Predictive modeling finds that the dialysate lactate concentration used for short daily HD may not be appropriate for nocturnal HD. Since the effect of lactate mainly depends on weekly dialysate volume, reducing from 60 to 30 liters for frequent nocturnal HD may be appropriate.
Read the abstract » | (added 2020-08-11)
Tags: Home Hemodialysis, Lactate, Acid Generation, Dialysate
-
C-reactive Protein to Albumin Ratio (CAR) on PD Predicts Survival
An analysis of 758 PD patients observed for up to 12 years found that those whose CAR was lower were significantly more likely to survive than those whose CAR was higher.
Read the abstract » | (added 2020-08-11)
Tags: Serum C reactive Protein To Albumin Ratio, Serum C reactive Protein, PD, Peritoneal Dialysis